SV2006002156A - Compuesto farmaceutico ref. 00346/sv - Google Patents

Compuesto farmaceutico ref. 00346/sv

Info

Publication number
SV2006002156A
SV2006002156A SV2005002156A SV2005002156A SV2006002156A SV 2006002156 A SV2006002156 A SV 2006002156A SV 2005002156 A SV2005002156 A SV 2005002156A SV 2005002156 A SV2005002156 A SV 2005002156A SV 2006002156 A SV2006002156 A SV 2006002156A
Authority
SV
El Salvador
Prior art keywords
pharmaceutical compound
compound ref
ref
methylpiridin
serinprotease
Prior art date
Application number
SV2005002156A
Other languages
English (en)
Spanish (es)
Inventor
Julie Kay Bush
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV2006002156A publication Critical patent/SV2006002156A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SV2005002156A 2004-06-30 2005-06-29 Compuesto farmaceutico ref. 00346/sv SV2006002156A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58359904P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
SV2006002156A true SV2006002156A (es) 2006-02-15

Family

ID=35276192

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002156A SV2006002156A (es) 2004-06-30 2005-06-29 Compuesto farmaceutico ref. 00346/sv

Country Status (19)

Country Link
US (1) US20070249623A1 (https=)
EP (1) EP1763521A1 (https=)
JP (1) JP2008505075A (https=)
CN (1) CN1984903A (https=)
AR (1) AR049659A1 (https=)
AU (1) AU2005267579A1 (https=)
BR (1) BRPI0512245A (https=)
CA (1) CA2570634A1 (https=)
EA (1) EA010307B1 (https=)
EC (1) ECSP067105A (https=)
IL (1) IL179903A0 (https=)
MA (1) MA28842B1 (https=)
MX (1) MXPA06015112A (https=)
NO (1) NO20070486L (https=)
PE (1) PE20060480A1 (https=)
SV (1) SV2006002156A (https=)
TW (1) TW200603806A (https=)
WO (1) WO2006011955A1 (https=)
ZA (1) ZA200610091B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
CN107365304A (zh) * 2017-08-01 2017-11-21 齐宜涛 一种治疗心血管疾病的化合物及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
EP1163217B1 (en) * 1999-03-15 2005-09-21 Novo Nordisk A/S New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
DE60022508T2 (de) * 1999-06-14 2006-06-08 Eli Lilly And Co., Indianapolis Inhibitoren von serin proteasen
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0019228D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
CA2447405C (en) * 2001-05-14 2006-10-17 Pfizer Products Inc. Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
TWI257389B (en) * 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound

Also Published As

Publication number Publication date
CN1984903A (zh) 2007-06-20
EA010307B1 (ru) 2008-08-29
WO2006011955A1 (en) 2006-02-02
JP2008505075A (ja) 2008-02-21
NO20070486L (no) 2007-01-25
AU2005267579A1 (en) 2006-02-02
IL179903A0 (en) 2007-05-15
MA28842B1 (fr) 2007-09-03
EA200700186A1 (ru) 2007-06-29
PE20060480A1 (es) 2006-07-13
TW200603806A (en) 2006-02-01
ZA200610091B (en) 2008-02-27
US20070249623A1 (en) 2007-10-25
MXPA06015112A (es) 2007-02-08
CA2570634A1 (en) 2006-02-02
BRPI0512245A (pt) 2008-02-19
ECSP067105A (es) 2007-01-26
AR049659A1 (es) 2006-08-23
EP1763521A1 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
DE602004011076D1 (de) Piperazin mit or-substituierter phenylgruppe und deren verwendung als glyt1-inhibitoren
HRP20090471T1 (hr) Derivati prolina i njihova upotreba kao inhibitori dipeptidil-peptidaze iv
CY1109529T1 (el) 2-(αμινο-υποκατεστημενες)-4-αρυλο πυραμιδινες και σχετικες ενωσεις που χρησιμευουν στην αγωγη φλεγμονωδων νοσηματων
UA94390C2 (ru) Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
HRP20120004T1 (en) Dipeptidyl peptidase inhibitors for treating diabetes
CY1106375T1 (el) Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας
CY1108428T1 (el) Μονοϋδροχλωρικο αλας 1-[3 [3-(4-χλωροφαινυλ) προποξυ] προπυλ] - πιπεριδινης
MY142441A (en) Azole derivatives as inhibitors of lipases and phospholipases
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
CY1112173T1 (el) Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας
DE602005017135D1 (de) Neue verwendung von pde5-hemmern
CY1112878T1 (el) Νεο αλας βενζοϋλογονανιδινης
SV2006002156A (es) Compuesto farmaceutico ref. 00346/sv
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
SV2003001085A (es) Compuesto farmaceutico
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
DE60321888D1 (https=)
AR048589A1 (es) Derivados de pirrolidina -3,4-dicarboxamida
DE60301569T2 (de) Bestimmte 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazin verbindungen als inhibitoren der serin protease factor xa
EA200602156A1 (ru) Новая комбинация ингибитора iтока синусового узла и кальциевого ингибитора и фармацевтические композиции, её содержащие
DOP2005000121A (es) Compuesto farmaceutico
JO2699B1 (en) New Association of a sinus node IF current inhibitor and an Angiotensin-Converting Enzyme inhibitor, and pharmaceutical compositions containing it.
PT1631291E (pt) Uso de inibidores tirosina quinase no tratamento de diabetes
DE602004010186D1 (de) Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2

Legal Events

Date Code Title Description
FD Lapse